What We Learned: Whose Death Is It Anyway? Medical Aid in Dying in NYS (Transformation Tuesday • March 31, 2026)
- Emily Trask
- 3 minutes ago
- 5 min read
At our March 31, 2026 Transformation Tuesday, Gray Panthers NYC explored one of the most intimate, difficult, and deeply human questions any society can face: Who gets to decide how a dying person dies? In a timely and thoughtful conversation, David Leven of End of Life Choices New York helped unpack New York’s newly signed Medical Aid in Dying Act, what it does, what it does not do, and why this issue is ultimately about dignity, autonomy, compassion, and justice.
Here are some of the most important takeaways from the conversation.
1) This law is about choice at the end of life, not about giving up on life
One of the clearest themes of the webinar was that medical aid in dying is not about choosing death over life. It is about giving terminally ill people—those already dying—the option to have some say over the manner and timing of an inevitable death. As David Leven emphasized, for people facing incurable, progressive illness, the question is often no longer whether they will die, but how they will die, and whether they will be allowed to make that decision for themselves.
2) Medical aid in dying is not the same as suicide
This distinction mattered throughout the discussion. Leven stressed that terminally ill patients seeking medical aid in dying are not “suicidal” in the conventional sense. They are not people who could otherwise expect to live long lives but are acting out of despair. They are dying people whose disease is already ending their lives, and who may want to avoid needless suffering, loss of dignity, or prolonged decline. He described medical aid in dying instead as a form of self-determination and, for many, self-preservation of identity and dignity.
3) New York’s law is tightly limited and carefully structured
The webinar made clear that the law is not broad or casual. It applies only to adults who are terminally ill, have decision-making capacity, are expected to die within six months, and are able to self-administer the medication. The process includes an oral request, a written request with witnesses, confirmation by two physicians, and a required mental health evaluation under the New York law, along with other procedural safeguards. It also allows patients to change their minds at any time.
4) The law recognizes that good hospice and palliative care still may not be enough for everyone
This was one of the more nuanced and important points in the conversation. Leven repeatedly affirmed the value of hospice and palliative care, and noted that most people who choose medical aid in dying are already receiving hospice. But even excellent end-of-life care cannot eliminate every kind of suffering. For some people, the deepest distress is not only physical pain, but the loss of autonomy, identity, dignity, or the ability to communicate and connect. For those patients, medical aid in dying may be the option that aligns most closely with their values.
5) The evidence from other states does not support the fears opponents often raise
A major part of the presentation addressed common concerns: coercion, abuse, disproportionate impact on vulnerable populations, or a “slippery slope.” Leven argued that the experience in states where medical aid in dying has been legal for years does not bear out those fears. He noted that there is no evidence of widespread coercion or abuse, no proven disproportionate impact on vulnerable groups, and no sign that these laws inevitably expand beyond terminal illness.
6) This conversation is also about disability, power, and who gets trusted to make decisions
The webinar did not avoid the harder ethical terrain. Leven addressed concerns raised by some in the disability community and acknowledged the real history of discrimination that disabled people face in medicine and society. At the same time, he argued that respecting autonomy means not assuming disabled people need to be “protected” from their own informed end-of-life choices simply because they are disabled. That tension—between protecting vulnerable people and respecting their agency—was one of the deepest moral currents running through the discussion.
7) Dementia remains one of the most painful unresolved areas
One of the most moving parts of the Q&A concerned Alzheimer’s disease and other dementias. Because the law requires decision-making capacity, many people with advanced dementia will not be eligible by the time they are close to death. That leaves families and advocates wrestling with difficult questions about advance directives, identity, future suffering, and whether the “former self” should be allowed to speak for the “current self.” The discussion made clear that while New York’s law is a major step, it does not solve every end-of-life dilemma.
8) Family support matters, but the decision belongs to the patient
Participants also asked what happens when family members oppose a loved one’s decision. Leven’s answer was direct: while family dynamics can be emotionally powerful, the decision rests with the person who is dying, as long as they have capacity. That principle—however difficult in practice—is at the heart of the law and of the broader ethics of bodily autonomy.
9) Access, equity, and implementation will be the next challenge
The law may be passed, but the work is not over. Questions about cost, coverage, provider participation, institutional policies, implementation, and public awareness remain. The speakers noted that many people do not even realize medical aid in dying is legal in states where it has already been authorized. That means education will be essential in the months ahead, especially before New York’s law takes effect. End of Life Choices New York and the American Academy of Aid in Dying are already working on implementation and outreach.
10) We were reminded to prepare before crisis comes
Michelle Arnot closed with a practical and important reminder: everyone should have a healthcare proxy in place. If this conversation taught us anything, it is that end-of-life decisions are too important to leave unspoken until the moment of crisis. The more we talk now—about values, wishes, fears, faith, dignity, and care—the more humane and loving those future decisions can be.
Final reflection
This webinar did not ask everyone to agree. It asked us to think more deeply, more compassionately, and more honestly about suffering, dignity, and freedom. Whatever one’s position, the conversation made clear that medical aid in dying is not a slogan or a shortcut. It is a profound end-of-life question—one that asks whether we trust dying people to know what matters most to them when time is short.
And perhaps that was the deepest lesson of all: at the end of life, dignity is not abstract. It is personal. It lives in choice, in truth-telling, in comfort, in being heard, and in being allowed to remain fully human until the very end.
